{
    "Trade/Device Name(s)": [
        "Elecsys Myoglobin Immunoassay",
        "Elecsys Myoglobin STAT Immunoassay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K083260",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983176"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DDR"
    ],
    "Summary Letter Date": "October 16, 2009",
    "Summary Letter Received Date": "October 1, 2009",
    "Submission Date": "September 30, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.5680"
    ],
    "Regulation Name(s)": [
        "Myoglobin immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Myoglobin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys immunoassay analyzers",
        "cobas e immunoassay analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Two-step sandwich immunoassay",
        "Electrochemiluminescence detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Myoglobin Immunoassay and Elecsys Myoglobin STAT Immunoassay for quantitative myoglobin measurement in serum and plasma using electrochemiluminescence on Elecsys and cobas e analyzers",
    "Indications for Use Summary": "For in vitro quantitative determination of myoglobin in human serum and plasma to aid in rapid diagnosis of heart and renal disease using Elecsys and cobas e immunoassay analyzers",
    "fda_folder": "Immunology"
}